Thermo Fisher Scientific reported Q1 EPS of $5.44, beating consensus $5.25, and revenue $11.01 bn, up 6% YoY.
Adjusted operating income rose 6% to $2.40 bn, with operating margin of 21.8%, marginally below last year’s 21.9%.
Despite the beat, shares slipped in pre‑market trading, and the company will announce revised 2026 targets at an 8:30 a.m. ET conference call.